What makes us different?
The government’s ever-increasing role as both regulator and payer is increasingly opaque, with massive implications for companies and investors alike. Legislators and regulators make critical decisions every day on healthcare issues that affect communities, and Capstone’s access to the policy world allows us to provide an array of insights. From micro studies of medical facilities to macro views of healthcare technology policy trends on the horizon, we provide clients differentiated investment ideas as well as deep-dive regulatory due diligence.
We live in the weeds.
Corporations and investors lean on Capstone’s expertise in healthcare policy to gain valuable insights on regulatory risks and global opportunities. Our process is designed to uncover innovative policy-driven ideas, advising private equity firms, corporations, and investors on the impact of regulation on potential and existing investments. We leverage our ability to wade through public records of existing and proposed regulation, legislation, and other policy efforts. We combine that with our relationships with major industry associations, as well as senior policymakers and influential experts, to add value and identify opportunities for investment growth.
Employee Retirement Income Security Act (ERISA)
Affordable Care Act
Pharmaceutical supply chain
Healthcare financial services
Our Latest Insights
By: Keegan Ferguson May 15, 2022 — While more than 30 states have legalized some form of the booming sports gambling market, California—the potential crown jewel of state sports wagering—has yet to get in the game. That may change this fall when Californians head to...
By: JB Ferguson May 9, 2022 — The Russian invasion of Ukraine in late February brought back for me vague memories of the mid-1980s, when the Iron Curtain separated the East and West and holiday dinners between my hippie-adjacent peacenik parents and “realist”...
By: Max Reale May 1, 2022 — With less than a dozen working weeks before the Senate departs for their August recess, Senate Democrats have failed to deliver the incremental progress we expected on a FY22 reconciliation package. Our initial cautious optimism that a deal...